Obseva announces U.S. FDA acceptance of new drug application for linzagolix
Obseva announced previously that the company has entered into a partnership with Syneos Health to support commercialization of linzagolix in the US and EU
Obseva announced previously that the company has entered into a partnership with Syneos Health to support commercialization of linzagolix in the US and EU
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)
Theradaptive's regenerative implants are best-in-class and are designed to permit precise tissue regeneration for a variety of tissue types and clinical indications
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
This is a shot in the arm for the vaccine manufacturers
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
Nelarabine is in a class of medications called antimetabolites
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
EaseVRx employs the principles of cognitive behavioural therapy and other behavioural therapy techniques for the reduction of pain and pain interference
Subscribe To Our Newsletter & Stay Updated